Watson-Marlow’s planned state-of-the-art manufacturing facility in Devens, Mass., will bring the company closer to its customers in the region. (Watson-Marlow/PRNewswire photo)

October 20, 2021

WILMINGTON, Mass.—Watson-Marlow, a manufacturer of peristaltic pumps and fluid management technologies for the life sciences and process industries, is planning to build a new state-of-the-art manufacturing facility in the United States that will support the company’s future growth in the America’s, Watson-Marlow said in a press release.

The planned 150,000-square-foot facility will be located in Devens, Massachusetts, close to the life sciences hub in the Cambridge-Boston area. It will be dedicated to manufacturing products that include peristaltic pumps, tubing, fluid path products, and BioPure components. First production is due in late 2022, according to the company.

Watson-Marlow’s Devens site will incorporate a suite of eight ISO14644-1 Class 7 cleanrooms, warehousing, and offices, and will have space for two further cleanrooms within the initial footprint. With separated cleanroom and non-cleanroom production capabilities, the new U.S. facility is expected to strengthen the support that Watson-Marlow provides to customers in the region across its core sectors of pharmaceutical and biotechnology, medical diagnostics, and process industries.

Watson-Marlow is part of Spirax-Sarco Engineering plc, a FTSE100 Company.

“The new U.S. facility is an important milestone in the Watson-Marlow company history and marks a significant commitment to serving our customers in the Americas region,” said Watson-Marlow Managing Director Andrew Mines, in the release. “This exciting development is bringing us closer to our customers whose purpose is to help the world around us, from advancing cell and gene therapies through to ensuring people have access to clean drinking water.

“Together, we will continue to develop market-leading fluid management solutions to engineer a more sustainable future,” Mines continued. “A huge thanks goes to the Watson-Marlow, BioPure, Americas, and Watson-Marlow Central Support teams that are making this happen, as well as to our parent Company, Spirax-Sarco Engineering, who have enabled us to make such a significant investment in our future.”

Watson-Marlow said in the release that the new facility will bring significant job opportunities to the local area, with more than 150 positions becoming available. Production at the new facility will replicate that of Watson-Marlow’s European sites, ensuring continued product quality for customers by using the same raw materials, components, processes, and work instructions, the company said.

Subscribe Now

Design-2-Part Magazine

Get the manufacturing industry news and features you need for free in a format you like.

FREE Print, Digital, or Both »

You have Successfully Subscribed!